Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 3/2013

01-03-2013 | Symposium: Papers Presented at the 2011 ISOLS Meeting in Beijing, China

Making a Case for the Socioeconomic Determinacy of Survival in Osteosarcoma

Authors: Saminathan S. Nathan, FRCS, John H. Healey, FACS

Published in: Clinical Orthopaedics and Related Research® | Issue 3/2013

Login to get access

Abstract

Background

The literature on osteosarcoma survival generally focuses on tumor and treatment variables, although it is unclear whether and how ethnic and socioeconomic factors might influence survival.

Questions/purposes

We therefore investigated the relative contribution of socioeconomic influences together with more traditional tumor-specific factors on osteosarcoma survival.

Methods

We performed survival analyses on two national databases in two countries. Using multivariable analyses, we compared these with corresponding institution-specific survival to determine if socioeconomic factors might impact osteosarcoma survival.

Results

East Asian descent, state-specific treatment, female sex, treatment in the 1990s, low-grade disease, intracompartmental disease, small size, wide resections as opposed to forequarter or hindquarter amputations, and single primaries were good prognostic factors. Survival was better in the more affluent states. Males were affected at an older age than females. Blacks tended to have larger tumors, although their overall survival was similar to whites. East Asians were more likely to be treated in the 1990s with wide resections for smaller tumors and were located around states associated with good treatment. East Asians in Singapore and the United States had the same survival. Survival in East Asians in Singapore was similar to that of other races. The provision of health care for osteosarcoma varies greatly across the United States but is uniform in the socialized medical system in Singapore. Hence, the observed differences in the United States were likely the result of socioeconomic factors.

Conclusions

Our analysis suggests ethnic and economic bias may influence survival in osteosarcoma and should receive greater attention in the collective literature on survival analyses.

Level of Evidence

Level II, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
go back to reference Bacci G, Briccoli A, Ferrari S, Longhi A, Mercuri M, Capanna R, Donati D, Lari S, Forni C, DePaolis M. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli’s 4th protocol. Eur J Cancer. 2001;37:2030–2039.PubMedCrossRef Bacci G, Briccoli A, Ferrari S, Longhi A, Mercuri M, Capanna R, Donati D, Lari S, Forni C, DePaolis M. Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli’s 4th protocol. Eur J Cancer. 2001;37:2030–2039.PubMedCrossRef
2.
go back to reference Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA, Saeter G, Donati D, Manfrini M, Lari S, Briccoli A, Forni C; Italian Sarcoma Group/Scandinavian Sarcoma Group. High dose ifosfamide in combination with high dose methotrexate, Adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother. 2002;14:198–206.PubMed Bacci G, Ferrari S, Longhi A, Picci P, Mercuri M, Alvegard TA, Saeter G, Donati D, Manfrini M, Lari S, Briccoli A, Forni C; Italian Sarcoma Group/Scandinavian Sarcoma Group. High dose ifosfamide in combination with high dose methotrexate, Adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother. 2002;14:198–206.PubMed
4.
go back to reference Enneking WF. Musculoskeletal Tumor Surgery. ed 1. New York, NY, USA: Churchill Livingstone; 1983. Enneking WF. Musculoskeletal Tumor Surgery. ed 1. New York, NY, USA: Churchill Livingstone; 1983.
5.
go back to reference Ganey PE, Thurman RG. Ethanol potentiates doxorubicin-induced inhibition of cell survival in cultured Chinese hamster ovary cells. Cancer Res. 1991;51:2036–2040.PubMed Ganey PE, Thurman RG. Ethanol potentiates doxorubicin-induced inhibition of cell survival in cultured Chinese hamster ovary cells. Cancer Res. 1991;51:2036–2040.PubMed
6.
go back to reference Gherlinzoni F, Picci P, Bacci G, Campanacci D. Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. Ann Oncol. 1992;3(Suppl 2):S23–S27.PubMedCrossRef Gherlinzoni F, Picci P, Bacci G, Campanacci D. Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience. Ann Oncol. 1992;3(Suppl 2):S23–S27.PubMedCrossRef
7.
go back to reference Greene FL. AJCC Cancer Staging Manual. ed. 6. New York, NY, USA: Springer-Verlag; 2002. Greene FL. AJCC Cancer Staging Manual. ed. 6. New York, NY, USA: Springer-Verlag; 2002.
8.
go back to reference Guo W, Xu W, Huvos AG, Healey JH, Feng C. Comparative frequency of bone sarcomas among different racial groups. Chin Med J (Engl). 1999;112:1101–1104. Guo W, Xu W, Huvos AG, Healey JH, Feng C. Comparative frequency of bone sarcomas among different racial groups. Chin Med J (Engl). 1999;112:1101–1104.
9.
go back to reference Huvos AG. Bone Tumors—Diagnosis, Treatment & Prognosis. ed. 2. Philadelphia, PA, USA: WB Saunders Co; 1991. Huvos AG. Bone Tumors—Diagnosis, Treatment & Prognosis. ed. 2. Philadelphia, PA, USA: WB Saunders Co; 1991.
10.
go back to reference Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma in the American black. Cancer. 1983;52:1959–1965.PubMedCrossRef Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma in the American black. Cancer. 1983;52:1959–1965.PubMedCrossRef
11.
go back to reference Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977;101:14–18.PubMed Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med. 1977;101:14–18.PubMed
12.
go back to reference Jaffe HL. Tumors and Tumorous Conditions of the Bones and Joints. Philadelphia, PA, USA: Lea & Febiger; 1958. Jaffe HL. Tumors and Tumorous Conditions of the Bones and Joints. Philadelphia, PA, USA: Lea & Febiger; 1958.
13.
go back to reference Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer. 1972;30:1627–1631.PubMedCrossRef Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer. 1972;30:1627–1631.PubMedCrossRef
14.
go back to reference Lai HC, Lai MP, Leung KS. Glucose-6-phosphate dehydrogenase deficiency in Chinese. J Clin Pathol. 1968;21:44–47.PubMedCrossRef Lai HC, Lai MP, Leung KS. Glucose-6-phosphate dehydrogenase deficiency in Chinese. J Clin Pathol. 1968;21:44–47.PubMedCrossRef
15.
go back to reference Liu Y, Thurman RG. Potentiation of Adriamycin toxicity by ethanol in perfused rat liver. J Pharmacol Exp Ther. 1992;263:651–656.PubMed Liu Y, Thurman RG. Potentiation of Adriamycin toxicity by ethanol in perfused rat liver. J Pharmacol Exp Ther. 1992;263:651–656.PubMed
16.
go back to reference Marcove RC, Mike V, Hajek JV, Levin AG, Hutter RV. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am. 1970;52:411–423.PubMed Marcove RC, Mike V, Hajek JV, Levin AG, Hutter RV. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am. 1970;52:411–423.PubMed
17.
go back to reference Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992;10:5–15.PubMed Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992;10:5–15.PubMed
18.
go back to reference Parekh HK, Sladek NE. NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide. Biochem Pharmacol. 1993;46:1043–1052.PubMedCrossRef Parekh HK, Sladek NE. NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide. Biochem Pharmacol. 1993;46:1043–1052.PubMedCrossRef
19.
go back to reference Rosen G, Nirenberg A, Caparros B, Juergens H, Kosloff C, Mehta BM, Marcove RC, Huvos AG. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7). Natl Cancer Inst Monogr. 1981;56:213–220.PubMed Rosen G, Nirenberg A, Caparros B, Juergens H, Kosloff C, Mehta BM, Marcove RC, Huvos AG. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7). Natl Cancer Inst Monogr. 1981;56:213–220.PubMed
20.
go back to reference Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am. 1986;68:1331–1337.PubMed Simon MA, Aschliman MA, Thomas N, Mankin HJ. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am. 1986;68:1331–1337.PubMed
21.
go back to reference Teng YS. Human liver aldehyde dehydrogenase in Chinese and Asiatic Indians: gene deletion and its possible implications in alcohol metabolism. Biochem Genet. 1981;19:107–114.PubMedCrossRef Teng YS. Human liver aldehyde dehydrogenase in Chinese and Asiatic Indians: gene deletion and its possible implications in alcohol metabolism. Biochem Genet. 1981;19:107–114.PubMedCrossRef
22.
23.
go back to reference US Cancer Statistics Working Group. United States Cancer Statistics: 2000 Incidence and Mortality. Atlanta, GA, USA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2000. US Cancer Statistics Working Group. United States Cancer Statistics: 2000 Incidence and Mortality. Atlanta, GA, USA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2000.
24.
go back to reference Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K. Adjuvant therapy of osteosarcoma—a Phase II trial: Southwest Oncology Group study 9139. Cancer. 2004;100:818–825.PubMedCrossRef Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K. Adjuvant therapy of osteosarcoma—a Phase II trial: Southwest Oncology Group study 9139. Cancer. 2004;100:818–825.PubMedCrossRef
Metadata
Title
Making a Case for the Socioeconomic Determinacy of Survival in Osteosarcoma
Authors
Saminathan S. Nathan, FRCS
John H. Healey, FACS
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 3/2013
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-012-2575-1

Other articles of this Issue 3/2013

Clinical Orthopaedics and Related Research® 3/2013 Go to the issue

Symposium: Highlights from the First Combined 2011 Meeting of the Musculoskeletal Tumor Society and Connective Tissue Oncology Society

Does Combined Open and Arthroscopic Synovectomy for Diffuse PVNS of the Knee Improve Recurrence Rates?

Symposium: Papers Presented at the 2011 ISOLS Meeting in Beijing, China

Editorial: Limb Preservation: Past and Present

Symposium: Papers Presented at the 2011 ISOLS Meeting in Beijing, China

Computer-assisted Tumor Surgery in Malignant Bone Tumors

Symposium: Highlights from the First Combined 2011 Meeting of the Musculoskeletal Tumor Society and Connective Tissue Oncology Society

Haptic Robot-assisted Surgery Improves Accuracy of Wide Resection of Bone Tumors: A Pilot Study